A retrospective review of glargine use in pregnancy

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 54, Issue 4, 2009, Pages 208-210

  Henderson, Cassandra E ^a   Machupalli, Surekha ^a   Marcano Vasquez, Heynelda ^a   Kerr, Patrick ^a   Reilly, Kevin D ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Euglycemia; Glargine; Hyperglycemia; Insulin

Indexed keywords

GLUCOSE; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; BIRTH WEIGHT; CESAREAN SECTION; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PERINATAL DEATH; PERINATAL PERIOD; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT;

ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; CAPILLARIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 66949172487     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Gamson K, Chia S, Jovanovic L: The safety and efficacy of in-sulin analogs in pregnancy. J Mat Fet al. Neonatal Med 2004; 15:26-34
2. Prescribing Information as of April 2000. [Prescribing insert distributed with Lantus (insulin glargine of rDNA origin) in-jection.] Parsippany, NJ, Aventis Pharmaceuticals, 2000
3. Holing EV, Beyer CS, Brown ZA, et al: Why don't women with diabetes plan their pregnancies? Diabetes Care 1998;21: 889-895